Arteries have thin muscles within their walls to be able to withstand the pressure of the heart pumping blood to the far reaches of the body. Veins don't have a significant muscle lining, and, within them, there is nothing pumping blood back to the heart except physiology. Blood returns to the heart because the body's large muscles squeeze the veins as they contract in their normal activity of moving the body. The normal activities of moving the body returns the blood back to the heart.
There are two types of veins in the leg; superficial veins and deep veins. Superficial veins lie just below the skin and are easily seen on the surface. Deep veins, as their name implies, are located deep within the muscles of the leg. Blood flows from the superficial veins into the deep venous system through small perforator veins. Superficial and perforator veins have one-way valves within them that allow blood to flow only in the direction of the heart when the veins are squeezed.
A blood clot (thrombus) in the deep venous system of the leg is not dangerous in itself. The situation becomes life-threatening when a piece of the blood clot breaks off (embolus, pleural=emboli), travels downstream through the heart into the pulmonary circulation system, and becomes lodged in the lung. Diagnosis and treatment of a deep venous thrombosis (DVT) is meant to prevent pulmonary embolism.
Clots in the superficial veins do not pose a danger of causing pulmonary emboli because the perforator vein valves act as a sieve to prevent clots from entering the deep venous system. They are usually not at risk of causing pulmonary embolism.
Serracor-NK a systemic enzyme formulation containing two enterically coated systemic enzymes: serrapeptase and nattokinase. Serrapeptase is clinically proven to dissolve fibrin throughout the blood stream and within non-living tissue within the body. Nattokinase is clinically proven to break down blood clots, improve circulation, and cleanse the veins and arteries. Peoplesuffering from Deep Vein Thrombosis ( DVT ) and Pulmonary Embolism will benefit from the use of Serracor-NK. When applying serrapeptase and nattokinase to your body's blood, you are taking a multi-enzymatic approach to the break down and dissolving of the blood clots and fibrin built up along your veins and arteries. The benefits of these two enzymes goes well beyond their use for the disformation of blood clotting. Nattokinase has been a highly recommended enzyme in Japan for over 20 years and its uses for anti-coagulation has climbed dramatically in the past 10 years as more clinical research has been conducted on its use against thrombotic conditions. Serrapeptase is the number 1 ingredient in all systemic formulas for the break down of fibrin (scar tissue). Fibrin is a protein marcophage that is formed when trauma or inflammation occurs in the body. Your body's reaction to this fibrin thrombosis is a immune response that is ineffective and will result in higher fibrin levels in the blood.
Serracor-NK is a effective alternative to DVT surgery and, depending on the length of this condition, users of Serracor-NK could make signifigant strides against DVT in a matter of months. People looking to add Serracor-NK to their supplemental regiment should also consider adding Serra RX80, an enterically coated serrapeptase product that, when coupled with Serracor-NK, puts people suffering from DVT in the best scencario to stop the formation of blood clots and thrombosis as well as dissolve fibrin formations in the veins and arteries. Below, we provide a suggested use dosage chart for users of both products.
Deep Vein Thrombosis Dosage Chart
SERRACOR-NK and Serra RX80
Introduction Phase7 days period(not needed for exsisting serracor users)
Therapeutic Phase30 days or until desiredresults (30-270 days)
Maintenance Phasetaken for 30-360days
(depending upon each person)
Capsule per day (x) a day
Capsule per day (x) a day
Capsule per day (x) a day
SERRACOR- NK
2 capsules a day for 3 days
3 capsules, 3x a day
1 capsule, 3x a day
Serra RX 80
1 capsule a day for 3 days
1 capsules, 3x a day
1 capsule, 2x a day
To view the clinical studies on Nattokinase and Serrapeptase please use the links below:
If you would like to purchase these product please scroll down below to go to the product page. If you have questions and would like to speak with a product specialist please call:1-800-404-8804.
Toll Free USA 1-877-404-8804 / INT'L 1-602-404-3384
Pivotal Health Products Corp.
4727 E. Bell Road, Suite 45-447
Phoenix, AZ 85032-9339 Toll Free in USA 1-877-404-8804
International calls only 1-602-404-3384 Email: sales@pivotalhealth.info Do not take Serracor-NKif your are currently taking blood thinning medication. Serracor-NK is not recommended for women who are pregnant or nursing as these groups have not been clinically tested. As always, consult with your doctor before taking Serracor-NK.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. For all conditions or illnesses, see a healthcare professional for a full evaluation, diagnosis or treatment plan.
